Good idea or overkill? Mandatory residency requirement sparks controversy
August 20th 2007A recent resolution by the American Society of Health-System Pharmacists to require postgraduate one-year residencies for all pharmacists involved in direct patient care, has long-term consequences-and brings long-term controversy.
Medicare eases restrictions on anemia drugs
August 20th 2007The Centers for Medicare and Medicaid Services has come out with new, less stringent rules on the coverage of two popular anemia drugs. The new rules apply mostly to cancer patients who receive chemotherapy that causes anemia and people with the bone marrow disorder myelodysplasia.
Study: Four percent with chronic pain abuse Rx drugs
August 13th 2007A study conducted by the University of Wisconsin found that 4% of chronic pain patients taking opioid drugs such as OxyContin (oxycodone HCI, Purdue Pharma) or Percocet (oxycodone HCI/acetaminophen, Endo Labs) abuse the medications.
Malaria drug available under CDC's IND protocol
August 13th 2007Patients with severe malaria who need parenteral therapy because they are unable to take oral medications may now benefit from treatment with artesunate, an unapproved therapy now available through a new CDC Investigational New Drug Application.
Police investigate NAPLEX cheating
August 13th 2007Materials and computers from the University of Georgia College of Pharmacy and the offices and home of professor Flynn Warren Jr., M.S., have been seized by U.S. marshals investigating cheating on the North American Pharmacist Licensure Examination (NAPLEX).
Study: Four percent with chronic pain abuse Rx drugs
August 13th 2007A study conducted by the University of Wisconsin found that 4% of chronic pain patients taking opioid drugs such as OxyContin (oxycodone HCI, Purdue Pharma) or Percocet (oxycodone HCI/acetaminophen, Endo Labs) abuse the medications.
HHS proposes requiring DMEPOS suppliers to provide bond
August 6th 2007Community pharmacies are smarting over a proposed rule by HHS that will help limit the Medicare program's risk by requiring all suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) to provide CMS with a surety bond.
FDA concerned about recalled contact lens solution
August 6th 2007Consumers may not be aware of the May recall of Complete MoisturePlus Multipurpose Contact Lens Solution manufactured by Advanced Medical Optics (AMO) and continue to use the recalled product. Several cases of Acanthamoeba keratitis reported to CDC involved the use of AMO Complete MoisturePlus after the recall was announced.